tm logo
SAJAZIR
Live/Registered
REGISTERED

on 13 Jun 2023

Last Applicant/ Owned by

21 JJ Thomson Ave

Cambridge

GB

CB30FA

Serial Number

90461564 filed on 12th Jan 2021

Registration Number

7081259 registered on 13th Jun 2023

in the Principal Register

Correspondent Address

Mary Frances Love

MUNCY, GEISSLER, OLDS & LOWE, P.C.

125 S. Royal St.

Alexandria, VA 22314

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SAJAZIR

The wording SAJAZIR has no meaning in a foreign language. Pharmaceutical agents for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceutical preparations forRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical agents for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceutical preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceuticals for the treatment of hereditary angioedema all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations, namely, pain relief medications; veterinary preparations for medical treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals; supplements for the treatment of hereditary angioedema; supplements for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels and transdermal patches; chemical preparations for the medical treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels and transdermal patches; Drug delivery agents consisting of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents for use in pharmaceutical preparations, drugs and medicines for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; medical drugs for the treatment of rare diseases, in particular for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of hereditary angioedema, medical enzyme preparations in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; enzyme preparations for veterinary purposes; medicinal preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; medicines for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Medical and veterinary preparations and articles, namely, pre-filled syringes containing a bradykinin B2 receptor antagonist for medical purposes; Pharmaceuticals and natural remedy preparations, for use in the treatment and management of hereditary angioedema; single-use pre-filled syringes containing a bradykinin B2 receptor antagonist; syringes sold filled with a bradykinin B2 receptor antagonist for subcutaneous injections in the treatment of acute attack of hereditary angioedema; single-use pre-filled syringes containing a bradykinin B2 receptor antagonist for subcutaneous injections in the treatment of acute attack of hereditary angioedema


First Use Date in General

23rd Sep 2022

First Use Date in Commerce

23rd Sep 2022

Mark Details


Serial Number

No 90461564

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 14218-102

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Jun 2023REGISTERED-PRINCIPAL REGISTER
13th Jun 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th May 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th May 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04th May 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
04th May 2023STATEMENT OF USE PROCESSING COMPLETE
18th Apr 2023TEAS STATEMENT OF USE RECEIVED
18th Apr 2023USE AMENDMENT FILED
18th Oct 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23rd Aug 2022PUBLISHED FOR OPPOSITION